MedPath

A clinical trial to study the effect of two drug, erand patranal kshar and salicylic acid on patients having wart.

Phase 2/3
Completed
Conditions
Disorder of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: MASHAKAH,
Registration Number
CTRI/2024/02/062468
Lead Sponsor
Goverment ayurved College and hospital nagpur
Brief Summary

After the institutional ethics clearance of the government Ayurved College and Hospital, Nagpur screening of the population will be done from patients in OPD, IPD, and the periphery of our institute in the clinical study of 60 patients of wart (Mashak) will be included. Assessment of the disease will be done according to the signs and symptoms of the wart. During the informed consent process, the subjects will be given enough time to read the Patient information sheet and consent form. Subjects will also be given the freedom to ask the questions and all the questions will be answered. If he or she agrees to participate in the study and if they found fit to be included during screening then he will be recruited into the study. If all inclusion criteria are YES and all exclusion criteria are NO then subjects will be included on the basis of the criteria given. Subjects will then undergo both general and systemic examination.

Medium of dissertation: The study will be written in English and Sanskrit words will be used wherever necessary.



Type of study: A randomized control trial.  Duration of treatment: 7 Days.



Ethical clearance: Clearance from the institutional ethics committee of our institute.



Study Centre: OPD IPD of Shalyatantra and Periphery of Nagpur.



Decoration of study: The study will be carried out for 18 months after approval of the synopsis



Treatment details:



| | | |

| --- | --- | --- |

| GroupGroup A (Trial group)Group B (Control group)

| Treatment Erand patranal kshir Salicylic acid

| No. of patients 3030

| Route of administration Local application (externally)Local application (externally)

| Dose Once in a day Once in a day

| Duration 7 days 7 days

| Follow up Every alternate day up to 1 week every alternate day Up to 1 week

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients willing to participate in the study.
  • Patients having age between 20-70 years will be considered.
  • Patients will be selected irrespective of sex, marital status, educational status.
  • Patients having warts anywhere on the body.
  • Patients having multiple warts.
  • Planter warts, periungual warts, filiform warts, genital warts, common warts.
  • Patients with controlled diabetis mellitus (HbA1C <6).
Exclusion Criteria
  • Mucosal warts.
  • Anaemic patients (Hb <6gm%).
  • Diabetic patients (uncontrolled).
  • Warts present near the periorbital region.
  • Patients with major uncontrolled illness.
  • Non-cooperative patients.
  • Immuno-compromised patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of erand patranal kshar in the management of mashak.7 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of salicylic acid in the management of Mashak7 days

Trial Locations

Locations (1)

Government ayurved college and hospital

🇮🇳

Nagpur, MAHARASHTRA, India

Government ayurved college and hospital
🇮🇳Nagpur, MAHARASHTRA, India
Dr Akash vijay chavhan
Principal investigator
9604593694
akashchavhan862@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.